Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Angiodynamics (ANGO) Return on Capital Employed (2016 - 2026)

Angiodynamics' Return on Capital Employed history spans 16 years, with the latest figure at 0.18% for Q1 2026.

  • For Q1 2026, Return on Capital Employed rose 5.0% year-over-year to 0.18%; the TTM value through Feb 2026 reached 0.18%, up 5.0%, while the annual FY2025 figure was 0.18%, 40.0% up from the prior year.
  • Return on Capital Employed reached 0.18% in Q1 2026 per ANGO's latest filing, down from 0.17% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.01% in Q3 2023 to a low of 1.17% in Q4 2024.
  • Average Return on Capital Employed over 5 years is 0.3%, with a median of 0.17% recorded in 2025.
  • Peak YoY movement for Return on Capital Employed: crashed -115bps in 2024, then soared 100bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.07% in 2022, then skyrocketed by 73bps to 0.02% in 2023, then plummeted by -6133bps to 1.17% in 2024, then surged by 86bps to 0.17% in 2025, then decreased by -7bps to 0.18% in 2026.
  • Per Business Quant, the three most recent readings for ANGO's Return on Capital Employed are 0.18% (Q1 2026), 0.17% (Q4 2025), and 0.18% (Q3 2025).